VAXCYTE, INC. Shares Outstanding
VAXCYTE, INC. (PCVX) had Shares Outstanding of 144.79 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-05
- 2026-06-30: Shares outstanding (split-adjusted) 144.79M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 144.31M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 131.06M shares; Shares authorized (split-adjusted) 500.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 130.03M shares; Shares authorized (split-adjusted) 500.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 144.79M shares 10-Q · filed 2026-08-05 | 500.00M shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 144.31M shares 10-Q · filed 2026-05-06 | 500.00M shares 10-Q · filed 2026-05-06 |
| 2025-12-31 | 131.06M shares 10-Q · filed 2026-08-05 | 500.00M shares 10-Q · filed 2026-08-05 |
| 2025-09-30 | 130.03M shares 10-Q · filed 2025-11-04 | 500.00M shares 10-Q · filed 2025-11-04 |
| 2025-06-30 | 129.82M shares 10-Q · filed 2025-08-06 | 500.00M shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 128.94M shares 10-Q · filed 2025-05-07 | 500.00M shares 10-Q · filed 2025-05-07 |
| 2024-12-31 | 124.89M shares 10-K · filed 2026-02-24 | 500.00M shares 10-K · filed 2026-02-24 |
| 2024-09-30 | 124.43M shares 10-Q · filed 2024-11-05 | 500.00M shares 10-Q · filed 2024-11-05 |
| 2024-06-30 | 110.58M shares 10-Q · filed 2024-08-06 | 500.00M shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 108.76M shares 10-Q · filed 2024-05-08 | 500.00M shares 10-Q · filed 2024-05-08 |
| 2023-12-31 | 95.36M shares 10-K · filed 2025-02-25 | 500.00M shares 10-K · filed 2025-02-25 |
| 2023-09-30 | 95.10M shares 10-Q · filed 2023-11-06 | 500.00M shares 10-Q · filed 2023-11-06 |
| 2023-06-30 | 93.81M shares 10-Q · filed 2023-08-08 | 500.00M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 80.64M shares 10-Q · filed 2023-05-08 | 500.00M shares 10-Q · filed 2023-05-08 |
| 2022-12-31 | 79.47M shares 10-K · filed 2024-02-27 | 500.00M shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 60.57M shares 10-Q · filed 2022-11-07 | 500.00M shares 10-Q · filed 2022-11-07 |
| 2022-06-30 | 58.62M shares 10-Q · filed 2022-08-08 | 500.00M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 56.50M shares 10-Q · filed 2022-05-09 | 500.00M shares 10-Q · filed 2022-05-09 |
| 2021-12-31 | 53.03M shares 10-K · filed 2023-02-27 | 500.00M shares 10-K · filed 2023-02-27 |
| 2021-09-30 | 52.59M shares 10-Q · filed 2021-11-10 | 500.00M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 51.96M shares 10-Q · filed 2021-08-11 | 500.00M shares 10-Q · filed 2021-08-11 |
| 2021-03-31 | 51.34M shares 10-Q · filed 2021-05-11 | 500.00M shares 10-Q · filed 2021-05-11 |
| 2020-12-31 | 51.07M shares 10-K · filed 2022-02-28 | 500.00M shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 50.95M shares 10-Q · filed 2020-11-12 | 500.00M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 50.88M shares 10-Q · filed 2020-08-12 | 66.00M shares 10-Q · filed 2020-08-12 |
| 2019-12-31 | 4.06M shares 10-K · filed 2021-03-29 | 52.00M shares 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |